Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
cancer
3
×
europe blog main
3
×
life sciences
national blog main
san francisco blog main
blueprint medicines
cancer drugs
eli lilly
europe top stories
fda
indiana blog main
indiana top stories
national top stories
novartis
san francisco top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
avapritinib
bioeurope
biogen
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
capmatinib
cara therapeutics
clinical trials
deciphera pharmaceuticals
deerfield management
detroit blog main
What
medicines
3
×
cancer
drug
fda
ipo
new
activity
address
approval
approvals
approves
bio
biogen
biotech
black
blueprint
carries
certain
clamped
clinic
companies
covid
delays
designed
developing
diamond
economic
eluded
fast
genetic
hopes
including
isn’t
latest
lead
leading
lines
lot
molecular
nears
Language
unset
Current search:
medicines
×
cancer
×
" boston top stories "
×
" europe blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
